Pulmonary

Potential new therapy for systemic sclerosis-related lung disease
The approach targets cGAS, or its downstream signaling pathways, as a key driver in treating the disease.
October 16, 2025
Getty Images 1446857023
Shared washrooms in care facility linked to increased risk of viral infections
New study advocates for design changes to minimize spread of infections.
October 16, 2025
Getty Images 2152102864
FDA approves IPF drug therapy nerandomilast
It becomes the first new treatment in more than a decade for the severe lung condition.
October 9, 2025
Getty Images 2186769687 Crop
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
AI-driven CT scan predicts lung disease outcomes at one year
The analysis can identify high-risk patients of fibrotic progression to initiate earlier treatment intervention.
October 6, 2025
Matthew Koslow, MD, and David Baraghoshi, PhD
Scientists propose ‘small lung syndrome’ category
The unique chronic lung condition impacts people with impaired lung function that differs from obstructive respiratory diseases.
October 3, 2025
Getty Images 635848020
Final trial data show significant benefits of sotatercept
The biologic drug helps reduce symptoms and slow progression of PH when treated early.
October 2, 2025
Getty Images 2185352631
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
A new outlook on lung scarring
Pain-detecting nerve cells also regulate inflammation and have bearing on pulmonary fibrosis.
September 25, 2025
Screenshot of computer image using advanced microscopy to look at lung immune cells causing lung fibrosis.
IL-10’s big role in pulmonary fibrosis
New research sheds light on the significance of the small protein in preventing lung inflammation.
September 25, 2025
UIC researchers Teruyuki Sano, PhD, (left) and Kiwook Kim, PhD, (right) have discovered that a small protein called IL-10 is critical for preventing lung inflammation and associated diseases.
Pulmonary foam cells contribute to long-COVID
The unique association may help researchers better understand prevention therapies for lasting damage.
September 18, 2025
Getty Images 1086669302
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
Phase 3 trial of efzofitimod falls short of primary endpoint
aTyr Pharma shared the results but affirmed it is not the end of the road for the developmental drug.
September 17, 2025
Getty Images 1301125470
IFITM3 drives SCLC immunotherapy response
The protein serves as a key indicator of how a patient with small cell lung cancer will react to current treatments.
September 10, 2025
Getty Images 2187784917
Peeling back the layers of pulmonary fibrosis
Exploration of the disease in early stages sheds light on initial chain reaction and inevitable feedback loop.
September 9, 2025
Claudia Loebel, MD, PhD, preparing samples in the lab.
Page 1 of 21
Next Page
Most Popular
Scientists propose ‘small lung syndrome’ category
AI-driven CT scan predicts lung disease outcomes at one year
FDA approves IPF drug therapy nerandomilast
Changes could boost access to noninvasive ventilation for COPD
One-two punch delivers relief for patients with severe asthma
A 2-in-1 inhaler proves more effective than salbutamol for mild pediatric asthma